Increasing rectum-prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancer.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 10 2023
Historique:
received: 17 04 2023
accepted: 20 10 2023
medline: 30 10 2023
pubmed: 27 10 2023
entrez: 26 10 2023
Statut: epublish

Résumé

SpaceOAR, a polyethylene-glycol hydrogel, reduces rectal radiation exposure during radiation therapy for prostate cancer. Previously, our group reported the modified technique of hydrogel insertion, which achieves greater separated distance at prostate-apex. This study aimed to investigate the impact of separated distance at prostate-apex and our modifier technique, on radiation exposure reduction during proton beam therapy (PBT). We included 330 patients undergoing PBT with the relative biological effectiveness (RBE) of 63 Gray (Gy) for localized prostate cancer, and categorized them into groups 0 (no spacer, n = 141), 1 (separated distance of spacer at the prostate-apex level < 7.5 mm, n = 81), and 2 (distance ≥ 7.5 mm, n = 108). The rectal volumes to receive 30-60 Gy (RBE), was estimated and described as Rectal V30-60 (ml) in 10 Gy increments. The Rectal V30-60 (ml) was significantly lower in group 2 than in group 1, and in group 1 than in group 0. After propensity score matching, the multivariate logistic regression analysis revealed that the most significant factor to reduce radiation exposure was our modified technique of hydrogel insertion. Therefore, using a hydrogel spacer to expand the prostate-rectum distance not only at prostate-mid to prostate-base level but also at the prostate-apex level can reduce the radiation exposure in PBT for prostate cancer.

Identifiants

pubmed: 37884786
doi: 10.1038/s41598-023-45557-7
pii: 10.1038/s41598-023-45557-7
pmc: PMC10603046
doi:

Substances chimiques

Hydrogels 0
Hydrogel, Polyethylene Glycol Dimethacrylate 25852-47-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

18319

Informations de copyright

© 2023. Springer Nature Limited.

Références

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-977
pubmed: 26054865
Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):81-7
pubmed: 23414766
Int J Urol. 2014 Apr;21(4):416-8
pubmed: 24118183
J Med Imaging Radiat Oncol. 2019 Dec;63(6):836-841
pubmed: 31520465
J Med Ultrason (2001). 2019 Oct;46(4):363-366
pubmed: 31564001
AJR Am J Roentgenol. 2022 Apr;218(4):757
pubmed: 34817190
Pract Radiat Oncol. 2022 May-Jun;12(3):226-235
pubmed: 34801769
Eur Urol Oncol. 2021 Dec;4(6):877-892
pubmed: 34716119
Int J Urol. 2022 Nov;29(11):1254-1263
pubmed: 35996758
BJU Int. 2012 Dec;110(11 Pt B):E647-52
pubmed: 22788857
Sci Rep. 2021 Mar 17;11(1):6165
pubmed: 33731856
Tomography. 2022 Oct 27;8(6):2648-2661
pubmed: 36412680
PLoS One. 2014 Apr 18;9(4):e94971
pubmed: 24747601
Pract Radiat Oncol. 2017 May - Jun;7(3):195-202
pubmed: 28089528
Int J Urol. 2020 Jan;27(1):60-66
pubmed: 31587417
Urology. 2018 May;115:39-44
pubmed: 29174940
Clin Oncol (R Coll Radiol). 2013 Aug;25(8):483-98
pubmed: 23810749
Radiat Oncol. 2013 Apr 23;8:96
pubmed: 23618548
Urology. 2013 Oct;82(4):963-8
pubmed: 24074991
JAMA Netw Open. 2020 Jun 1;3(6):e208221
pubmed: 32585020
Jpn J Clin Oncol. 2022 Feb 5;52(2):170-178
pubmed: 34689189
J Med Ultrason (2001). 2022 Oct;49(4):751-752
pubmed: 36114322
Jpn J Clin Oncol. 2020 Sep 5;50(9):963-969
pubmed: 32580211
JAMA Oncol. 2023 Apr 1;9(4):511-518
pubmed: 36757690
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1918-22
pubmed: 21514738
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Eur Urol. 2012 Jan;61(1):112-27
pubmed: 22001105
Adv Radiat Oncol. 2021 May 09;6(4):100713
pubmed: 34195499
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e329-36
pubmed: 21703781
Brachytherapy. 2009 Apr-Jun;8(2):210-217
pubmed: 19213607
Urology. 2021 Oct;156:e74-e85
pubmed: 34029607
Adv Exp Med Biol. 2018;1096:31-47
pubmed: 30324346
Int J Urol. 2023 Jan;30(1):116-118
pubmed: 36482782

Auteurs

Tsukasa Narukawa (T)

Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan. tnarukaw@koto.kpu-m.ac.jp.

Norihiro Aibe (N)

Department of Radiology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.

Masashi Tsujimoto (M)

Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.

Takumi Shiraishi (T)

Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.

Takuya Kimoto (T)

Department of Radiology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.

Gen Suzuki (G)

Department of Radiology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.

Takashi Ueda (T)

Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.

Atsuko Fujihara (A)

Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.

Hideya Yamazaki (H)

Department of Radiology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.

Osamu Ukimura (O)

Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji 465, Kyoto, Kyoto, 602-8566, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH